Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.
Also called NCT01069302
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 106 participants
- Sponsor
- Registry
-
NCT01069302
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01069302. Randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2011-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan
- Acronym
- CHOICE
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Takeshi Morimoto
Record details
- Record id
cardio:ct-nct01069302- Content hash
b80d2d9f6009bffbfcb57bd50f4c88108e88e2f063a4f655c93cd2fe7dc7a82f